Table 2.
Population summary by tumor type (solid tumor or hematologic malignancy)
| Solid tumors (n = 1136) | Hematological malignancy (n = 276) | |
|---|---|---|
| Male sex – n (%) | 548 (48) | 141 (51) |
| Age – median (Q1, Q3) | 64.0 (55.0, 71.0) | 68.0 (56.5, 74.0) |
| Number of chemotherapy cycles completed since initiation – n (%) | ||
| In first cycle | 163 (14) | 45 (16) |
| 1–3 | 477 (42) | 124 (45) |
| 4–6 | 304 (27) | 69 (25) |
| >6 | 192 (17) | 38 (14) |
| Current chemotherapy regimen containsa – n (%) | ||
| Platinum | 457 (40) | 20 (7) |
| Anthracycline | 134 (12) | 101 (37) |
| Taxane | 216 (19) | 0 (0) |
| Missingb | 414 (36) | 155 (56) |
| Currently undergoing radio-chemotherapy – n (%) | 54 (5) | 3 (1) |
Notes:
a
Patients may be recorded in multiple chemotherapy type categories;
b
An unexpected number of patients had therapies other than those listed on the case report form and were therefore categorized as ‘missing’.